CHFS
(NASDAQ)
0.4683
+0.1244  (+26.57%)
Volume (24h): 10.28M Day Range: 0.3602 - 0.4980
Market Cap: 9.74M 52W Range: 0.3000 - 4.87
Mar-25-20 12:00PM CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid ManagementGlobeNewswire
Mar-20-20 12:30PM CHF Solutions, Inc. Announces Pricing of Registered Direct OfferingGlobeNewswire
Mar-19-20 12:00PM CHF Solutions’ Aquadex FlexFlow® System is licensed and approved for sale in IndiaGlobeNewswire
Mar-18-20 12:00PM CHF Solutions Webinar Highlighted Importance of Fluid Management in Patients Treated for COVID-19GlobeNewswire
Mar-13-20 12:00PM CHF Solutions to Host Clinician Webinar on Use of Ultrafiltration for Volume Management in Patients Treated for COVID-19GlobeNewswire
Mar-12-20 12:07PM Benzinga Pro's Top 5 Stocks To Watch For Thurs., Mar. 12, 2020: BA, APT, UBER, APRN, CHFSBenzinga
Mar-03-20 01:00PM CHF Solutions, Inc. Announces Fourth Quarter Financial Results and Provides Company UpdateGlobeNewswire
Feb-26-20 01:00PM CHF Solutions receives 510(k) clearance for Aquadex SmartFlow™ system in Pediatric Patients Weighing 20kg or MoreGlobeNewswire
Feb-25-20 01:00PM CHF Solutions, Inc. To Announce Fourth Quarter and Year-End 2019 Financial Results on March 3, 2020GlobeNewswire
Feb-12-20 02:15PM CHF Solutions Expands Commercial Presence in Europe with Distribution Arrangement for Germany, Austria and SwitzerlandGlobeNewswire
Feb-11-20 09:45PM CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
Feb-05-20 01:00PM CHF Solutions Receives CE Mark for its New Aquadex SmartFlow™ ConsoleGlobeNewswire
Jan-30-20 01:00PM CHF Solutions Expands its Patent Portfolio with Four Applications for Innovations for Aquapheresis TherapyGlobeNewswire
Jan-28-20 09:10PM CHF Solutions, Inc. Announces Closing of $9.66 Million Underwritten Public Offering and Full Exercise of Over-Allotment OptionGlobeNewswire
Jan-24-20 02:37PM CHF Solutions, Inc. Announces Pricing of $8.4 Million Underwritten Public OfferingGlobeNewswire
Jan-22-20 01:00PM CHF Solutions Announces Launch of Aquapheresis Therapy Using Aquadex FlexFlow® System at the Baylor Scott & White Health System in TexasGlobeNewswire
Jan-08-20 01:00PM CHF Solutions Announces Presentation of Clinical Data with Aquadex FlexFlow® Highlighting Efficacy and Simplicity of Use In Treating Critical Care PatientsGlobeNewswire
Dec-03-19 01:00PM CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Memphis Methodist Le Bonheur Healthcare SystemGlobeNewswire
Nov-15-19 10:30PM CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
Nov-05-19 01:00PM CHF Solutions, Inc. Announces Third Quarter Financial Results and Provides Company UpdateGlobeNewswire
Nov-04-19 02:19PM CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-MarketGlobeNewswire
Nov-01-19 12:00PM CHF Solutions, Inc. Announces Sales Force Realignment To Increase Focus On Cardiac Surgery And Eventually PediatricsGlobeNewswire
Oct-31-19 08:17PM Penny Stocks to Buy Using Technical Analysis for November 2019Investopedia
Oct-29-19 12:00PM CHF Solutions, Inc. To Announce Third Quarter 2019 Financial Results and Corporate Update on November 5, 2019GlobeNewswire
Oct-24-19 12:00PM Abington Hospital Begins a 344 Patient Retrospective Clinical Study to Analyze Experience with CHF Solutions’ Aquadex FlexFlow® SystemGlobeNewswire
Oct-23-19 01:10PM CHF Solutions, Inc. Announces Pricing of Registered Direct OfferingGlobeNewswire
Oct-17-19 12:30PM CHF Solutions to Exhibit at The American College of Chest Physicians (CHEST) Annual Meeting 2019GlobeNewswire
Oct-15-19 12:00PM MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019ACCESSWIRE
Oct-14-19 01:35PM CHF Solutions System to be Used in JAHVH Study After Final NodZacks
Oct-10-19 12:00PM CHF Solutions Announces that James A. Haley Veterans’ Hospital Receives Final Approval To Initiate Heart Failure Outpatient Study utilizing Aquadex FlexFlow® SystemGlobeNewswire
Oct-08-19 12:00PM CHF Solutions, Inc. to Present at the MicroCap Rodeo Investor Conference on October 15, 2019GlobeNewswire
Oct-03-19 12:30PM CHF Solutions To Exhibit at Upcoming Heart Failure ConferencesGlobeNewswire
Oct-01-19 12:00PM CHF Solutions submits 510(k) application for Use of Aquadex FlexFlow® System with Pediatric PatientsGlobeNewswire
Sep-24-19 06:20PM Market Morning: Prorogation Ruled Rogue, High Demand for Fed Repo, New Breast Cancer TestsMarket Exclusive
12:00PM Multi-Center, Retrospective Study Evaluates Use of Ultrafiltration Therapy with Aquadex FlexFlow® System in Pediatric PatientsGlobeNewswire
Sep-19-19 02:15PM The MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin TexasACCESSWIRE
12:00PM CHF Solutions, Inc. to Present at the Ladenburg Thalmann’s 2019 Healthcare Conference on September 24, 2019GlobeNewswire
Sep-17-19 12:00PM CHF Solutions, Inc. to Host a Call with Investigator Panel to Discuss Results of a Study Involving Use of Aquadex FlexFlow® in Pediatric Patients on September 25, 2019GlobeNewswire
Sep-10-19 12:00PM CHF Solutions, Inc. to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of AmericaGlobeNewswire
Sep-06-19 08:15PM CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
Sep-04-19 12:00PM CHF Solutions, Inc. Appoints World-Renowned Heart Failure Cardiologist, Maria Rosa Costanzo, M.D. to Company’s Board of DirectorsGlobeNewswire
Aug-23-19 04:12PM How Many CHF Solutions, Inc. (NASDAQ:CHFS) Shares Do Institutions Own?Simply Wall St.
Aug-08-19 11:00AM New Publication Highlights Transient Increases in Creatinine or Tubular Injury Markers in Heart Failure Patients Should Not Dissuade Use of UltrafiltrationGlobeNewswire
CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)